Equities

Astrazeneca Pharma India Ltd

ASTRAZEN:NSI

Astrazeneca Pharma India Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)6,319.85
  • Today's Change39.35 / 0.63%
  • Shares traded11.76k
  • 1 Year change+35.88%
  • Beta0.4967
Data delayed at least 15 minutes, as of Nov 22 2024 10:21 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
REVENUE AND GROSS PROFIT
Total revenue12,95510,0308,056
OPERATING EXPENSES
Cost of revenue total6,7814,3083,656
Selling, general and admin. expenses, total4,1903,9723,436
Depreciation/amortization149163170
Unusual expense(income)(152)402--
Other operating expenses, total12199101
Total operating expense11,0898,9437,362
Operating income1,8661,086694
Other, net132.104.60
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes2,1951,341830
Provision for income taxes580348214
Net income after taxes1,615993616
Minority interest------
Net income before extra. Items1,615993616
Total extraordinary items------
Net income1,615993616
Inc.avail. to common excl. extra. Items1,615993616
Inc.avail. to common incl. extra. Items1,615993616
EPS RECONCILIATION
Basic/primary weighted average shares252525
Basic/primary eps excl. extra items654025
Basic/primary eps incl. extra items654025
Dilution adjustment------
Diluted weighted average shares252525
Diluted eps excl. extra items654025
Diluted eps incl. extra items654025
COMMON STOCK DIVIDENDS
DPS - common stock primary issue241610.00
Gross dividend - common stock600400250
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental5.206.309.50
SUPPLEMENTAL INCOME
Depreciation, supplemental148163170
Total special items(152)377(28)
NORMALISED INCOME
Normalized income before taxes2,0431,718802
Effect of special items on income taxes(40)98(7.28)
Income tax excluding impact of special items540446207
Normalized income after tax1,5031,272595
Normalized income avail. to common1,5031,272595
Basic normalized EPS605124
Diluted normalized EPS605124
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.